Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review

Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review

Abstract Background In many industrialized countries routine vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPSV-23) is recommended to prevent pneumococcal disease in the elderly. However, vaccine-induced immunity wanes after a few years, and there are controversies around revac...

Full description

Bibliographic Details
Main Authors: Cornelius Remschmidt, Thomas Harder, Ole Wichmann, Christian Bogdan, Gerhard Falkenhorst
Format: Article
Language:English
Published: BMC 2016-11-01
Series:BMC Infectious Diseases
Subjects:
Antibody Level
Pneumococcal Disease
Primary Dose
Primary Vaccination
Pneumococcal Polysaccharide Vaccine
Online Access:http://link.springer.com/article/10.1186/s12879-016-2040-y

Similar Items

Similar Items